Lantheus Holdings (LNTH) Liabilities and Shareholders Equity (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Liabilities and Shareholders Equity came in at $2.4 billion in Q2 2026, up 14.11% year-over-year from $2.1 billion in Q2 2025, and up 2.9% quarter-over-quarter from $2.3 billion in Q1 2026.
Analysis
Lantheus Holdings (LNTH) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 14.11% year-over-year to $2.4 billion in Q2 2026; TTM through Jun 2026 was $9.3 billion, a 12.97% increase from a year earlier, with the FY2025 full-year figure at $2.2 billion, up 12.48% from the prior year.
- Liabilities and Shareholders Equity was $2.4 billion for Q2 2026 at Lantheus Holdings, up from $2.3 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $2.4 billion in Q2 2026 and troughed at $933.2 million in Q1 2022.
- A 5-year average of $1.7 billion and a median of $1.9 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity surged 52.96% in 2022 and grew 9.09% in 2025, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $1.3 billion in 2022, then climbed by 24.97% to $1.7 billion in 2023, then advanced by 19.94% to $2.0 billion in 2024, then climbed by 12.48% to $2.2 billion in 2025, then climbed by 8.41% to $2.4 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.4 billion (Q2 2026), $2.3 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 37.25 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 2.41 Bn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 344.46 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 283.00 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 166.35 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 1.10 Bn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | 30.24 Mn |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 5.72 Bn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 153.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Bn |
| Mar 31, 2026 | 2.35 Bn |
| Dec 31, 2025 | 2.23 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.12 Bn |
| Mar 31, 2025 | 2.06 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.94 Bn |
| Mar 31, 2024 | 1.83 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 1.52 Bn |
| Jun 30, 2023 | 1.34 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 933.17 Mn |
| Dec 31, 2021 | 863.78 Mn |
| Sep 30, 2021 | 847.82 Mn |